Volume III, Appendices EM - National Marine Fisheries Service ...

More documents

Recommendations

Info

2. Future ESA/MMPA Permit Activities 2.1.1 Blood Sampling Currently, no procedures exist to remotely collect blood from free-swimming animals. However, if blood sampling procedures are developed and approved within the timeframe of the permit (five years), the MMHSRP would use these to conduct research. All protocols (including species) would be provided to NMFS PR1 for approval prior to any research activity. 2.1.2 Health Assessment Studies In addition to the current health assessment studies on bottlenose dolphins, future studies would be conducted on other cetacean species. New tagging, tracking, and telemetry packages would also be used. All species and methods would be provided to NMFS PR1 for approval before any activities occurred. 2.1.3 Acoustics Currently, the use of AEP procedures on any mysticete is not permitted by NMFS PR1. However, if mysticete procedures are approved within the timeframe of the permit (five years), the MMHSRP would use these to conduct research. All protocols (including species) would be provided to NMFS PR1 for approval prior to any research activity. Passive acoustic recording would involve the used of a hydrophone (underwater microphone). A hydrophone would be placed in the water directly off of a vessel, and sounds would be recorded and taped via an apparatus on the vessel. Active acoustic playbacks would be used to expose cetaceans and pinnipeds to playbacks of prerecorded songs, social sounds, and feeding calls of that species. Sounds and songs would be projected from an underwater speaker hung over the side of a small vessel. Sounds or songs would be projected from the speaker at a volume and quality as close to a real sound/song as possible. The playback system would be calibrated so precise levels of sound can be projected. The reaction of the animals to the sounds and songs would be measured, often through behavioral observation and photoidentification/video recording of the subject animal(s) from a second vessel. 2.1.4 Vaccination Program [Section not completed.] H-2-18
The pinniped vaccination program would use information from the Final Report of the Workshop to Evaluate the Potential for Use of Morbillivirus Vaccination in Hawaiian Monk Seals and from the vaccine trial subcommittee that was started at this workshop (HSWRI 2006). The pinniped vaccine study would include the use of harbor seals, northern elephant seals, and Hawaiian monk seals. The vaccine would be used to protect individual monk seals and prevent the spread of Morbillivirus. A vaccine would only be used if there was a threat of an epidemic. A vaccination program would include a plan for vaccine trials in a laboratory and field setting and a vaccination plan for wild seals. Vaccine testing and implementation would proceed slowly and in a stepwise fashion. Laboratory and field trials with Hawaiian monk seals would not be conducted until protocols and safety and efficacy concerns have been addressed in at least one model species (see below for description). Trials in model species would provide more information on safety than efficacy. Some in vitro measures may be developed, but there would be no way to evaluate efficacy without a disease challenge. Before beginning a vaccine trial, a method would be in place to allow expert review of the results at each testing stage and to ensure that the review occurs before continuing with the next stage. Samples sizes for vaccine trials would be constrained by the availability of animals for testing. Drug companies that produce vaccines could be contacted to provide guidance on ideal or recommended sample sizes for vaccine trials. Harbor seals would be used as a model for Hawaiian monk seals. There is a relatively large sample size of harbor seals in captivity that could be considered for vaccine trials. Vaccine trials have already been conducted in the United Kingdom (UK) on harbor seals. Some information from these trials is available with regard to issues such as post-vaccination monitoring protocols. Harbor seals have also shown susceptibility to wild strains of the virus and some protection from a vaccine in limited UK trials. Elephant seals may also be used as a model species because they are more closely related to Hawaiian monk seals. If elephant seals in rehabilitation are used as trial subjects, they could be declared nonreleasable (e.g., if they are shedding a virus) after a vaccine trial. Animals that are likely to be euthanized for other reasons could be possible trial subjects. Post-mortem exams could be conducted on the animals that were vaccinated and then euthanized, allowing for careful examination of the lymph nodes (for evidence of immunosuppression) and target organs like the brain. H-2-19
Page 1:
Draft Programmatic Environmental Im
Page 5 and 6:
Table E-1. Protected and Sensitive
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Bird Island Marine Sanctuary Table
Page 17 and 18:
Table E-7. Protected Fisheries Reso
Page 19 and 20:
Common Name Table E-10. Protected B
Page 21 and 22:
Common Name Table E-12. Protected B
Page 23 and 24:
Common Name Guam bridled white-eye
Page 25 and 26:
Table E-14. Marine Mammals Common i
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 40 and 41:
Marine Mammal Stranding Network Org
Page 42 and 43:
Organization/Individual NMFS Southw
Page 44 and 45:
Organization/Individual NMFS Pacifi
Page 46 and 47: Individual NMFS Southeast Region (c
Page 48 and 49: Individual NMFS Alaska Region Organ
Page 50 and 51: Individual NMFS Pacific Islands Reg
Page 53 and 54: Teri Rowles, D.V.M., Ph.D. National
Page 55 and 56: Authorization UNITED STATES DEPARTM
Page 57 and 58: PROJECT I1 - ENHANCEMENT ACTIVITIES
Page 59 and 60: . Euthanasia 1) 2) The NMFS Nationa
Page 61 and 62: g. The Holder/PI must not harass or
Page 63 and 64: meets the minimum standards of coll
Page 65 and 66: 2) Live captures; Stranding respons
Page 67 and 68: 4. Persons who require state, Feder
Page 69 and 70: 1 1. Any falsification of informati
Page 71 and 72: Florida Keys National Marine Sanctu
Page 73 and 74: Seattle, Washington 981 58 Blaine 9
Page 75 and 76: 50 CFR $21 6.37 Marine mammal parts
Page 77: APPENDIX H GENERAL DESCRIPTIONS OF
Page 80 and 81: oats. Animals are located by having
Page 82 and 83: In some cases, animals may need to
Page 84 and 85: ecorders (TDRs), life history trans
Page 86 and 87: LHX tags are satellite linked, dela
Page 88 and 89: analyzed. During live animal respon
Page 90 and 91: 1.1.12 Ultrasound Sampling Ultrasou
Page 92 and 93: interfaced to a laptop computer. Th
Page 94 and 95: Recording, ground, and reference su
Page 98 and 99: 3. References Dierauf 1994 Dierauf,
Page 100 and 101: 4. Acronyms ABR Auditory Brainstem
Page 103 and 104: Table 1. Proposed activities over a
Page 105 and 106: Table 1. Proposed activities over a
Page 108 and 109: PERSISTENT CONTAMINANTS IN SELECTED
Page 110 and 111: Table 2. Metadata for Persistent Or
Page 112 and 113: (PCDDs) oxygen atoms. Like PCBs, PC
Page 114 and 115: Although no physiologic requirement
Page 116 and 117: II.B. Concentrations of environment
Page 118 and 119: species targeted in this review, Ca
Page 120 and 121: data exist pertaining to contaminan
Page 122 and 123: _____, 2002c. Draft toxicological p
Page 124 and 125: Houde, M, Wells, R, Fair, P, Bossar
Page 126 and 127: Neale, J., Gulland, F., Schmeltzer,
Page 128 and 129: Tuerk, K, Kucklick, J., Becker, P.,
Page 130 and 131: Table 1. Summary of Concentrations
Page 132 and 133: Table 3. Polychlorinated dibenzo-p-
Page 134 and 135: Appendix III. Mercury, Cadmium, Lea
Page 136 and 137: Cadmium (Cd) (continued) Species Ti
Page 138 and 139: Lead (Pb) (continued) Mean Date Spe
Page 140 and 141: h Standard error of the mean i For
Page 142 and 143: Euthanasia Questionnaire Response S
Page 145 and 146: Prescott Overview FY01-07 Running T
Page 147 and 148:
YEAR STATE APPLICANT TITLE 2002 200
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
YEAR STATE APPLICANT TITLE FEDERAL
Page 155 and 156:
Page 157 and 158:
YEAR STATE APPLICANT TITLE 2005 FL
Page 159 and 160:
YEAR STATE APPLICANT TITLE FEDERAL
Page 161:
APPENDIX L MARINE MAMMAL OIL SPILL
Page 164 and 165:
This page left blank intentionally
Page 166 and 167:
NOTICE MARINE MAMMAL OIL SPILL RESP
Page 168 and 169:
MARINE MAMMAL OIL SPILL RESPONSE GU
Page 170 and 171:
Page 172 and 173:
Organizational Structure Organizati
Page 174 and 175:
Page 176 and 177:
Stranding Network and Facility Requ
Page 178 and 179:
Page 180 and 181:
Sample Collection and Label: It is
Page 182 and 183:
Page 184 and 185:
Wildlife Recovery and Transportatio
Page 186 and 187:
Page 188 and 189:
Intake Procedures Initial Intake Pr
Page 190 and 191:
Page 192 and 193:
Animal Washing and Continued Care G
Page 194 and 195:
Page 196 and 197:
Disposition Release The goal in reh
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Appendix 1. Search Effort Log Searc
Page 208 and 209:
Appendix 2b. Live Marine Mammal Dat
Page 210 and 211:
Appendix 3b. Dead Marine Mammal Dat
Page 212 and 213:
Appendix 5. Oiled Marine Mammal Dai
Page 214 and 215:
Appendix 7. Petroleum Hydrocarbon T
Page 216 and 217:
Appendix 8. Oil Spill Response Labo
Page 218 and 219:
Appendix 10. Chain of Custody Form
Page 220 and 221:
Intentional Blank Page
Page 223 and 224:
Table 1: Summary of overall statewi
Page 225 and 226:
Table 3: Summary of statewide infor
show all

Volume III, Appendices EM - National Marine Fisheries Service ...

Create successful ePaper yourself

Delete template?

Save as template?